Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Adjuvant T-DM1 improved invasive disease-free survival (IDFS) in patients with HER2-positive early breast cancer with residual invasive disease at...
Subgroup analysis suggested the treatment may benefit patients with nonbasal-like disease SAN ANTONIO Treating patients who had early-stage triple-negative...
NEW ORLEANS – African-Americans caring for loved ones with cancer were less likely than their white peers to report...
NEW ORLEANS – An interactive online LGBT cultural competency training program for oncologists may be acceptable, feasible, and improve...
NEW ORLEANS – A culturally tailored multilevel strategy designed to remove barriers to human papillomavirus (HPV) vaccination among low-income,...
NEW ORLEANS – An evaluation of breast cancer patients enrolled in Medicaid showed that states that expanded Medicaid during...
NEW ORLEANS – A prognostic model developed using a machine learning approach could identify African-American breast cancer patients with...